Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-08-20
DOI
10.1038/srep06098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple components of the spliceosome regulate Mcl1 activity in neuroblastoma
- (2014) T W Laetsch et al. Cell Death & Disease
- Chemical Perturbation of Mcl-1 Pre-mRNA Splicing to Induce Apoptosis in Cancer Cells
- (2013) Yang Gao et al. ACS Chemical Biology
- Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines
- (2013) Remco Nagel et al. ORAL ONCOLOGY
- Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing
- (2011) Liying Fan et al. ACS Chemical Biology
- Targeting Mcl-1 for the therapy of cancer
- (2011) Bridget A Quinn et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Functional consequences of developmentally regulated alternative splicing
- (2011) Auinash Kalsotra et al. NATURE REVIEWS GENETICS
- HPV16 E2 could act as down-regulator in cellular genes implicated in apoptosis, proliferation and cell differentiation
- (2011) Eric Ramírez-Salazar et al. Virology Journal
- The natural history of human papillomavirus infections of the mucosal epithelia
- (2010) LOUISE T. CHOW et al. APMIS
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis
- (2010) Michael J. Moore et al. CELL
- MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated manner
- (2010) Marc Germain et al. EMBO JOURNAL
- Secondary necrosis: The natural outcome of the complete apoptotic program
- (2010) Manuel T. Silva FEBS LETTERS
- Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation
- (2010) S. Rosenberger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus–Related Head and Neck Cancer
- (2009) William C. Spanos et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion
- (2009) Monica Cricca et al. JOURNAL OF MEDICAL VIROLOGY
- Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
- (2008) Anil K. Chaturvedi et al. JOURNAL OF CLINICAL ONCOLOGY
- Human Papillomavirus Type 16 E2 Protein Transcriptionally Activates the Promoter of a Key Cellular Splicing Factor, SF2/ASF
- (2008) S. Mole et al. JOURNAL OF VIROLOGY
- Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes
- (2008) Lulzim Shkreta et al. MOLECULAR CANCER THERAPEUTICS
- Alternative isoform regulation in human tissue transcriptomes
- (2008) Eric T. Wang et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started